Sanofi Says Kevzara Drug Fails To Meet Endpoints in Covid-19 Study
Genetic Engineering, No Virus Required
Panic attack signs – and what to do if you have one
College students access eating disorders therapy via phone app
Vir Bio and GSK Join the Race for a Covid-19 Monoclonal Antibody Therapy
UC study: Cancer, COVID-19 and blood clots
3 Monster Growth Stocks That Still Have Room to Run
Digital health firm Lyra enters unicorn territory after fundraising
Billionaire Israel Englander Goes Big on These 3 Penny Stocks
Transplanting Human Brown-Like Fat Cells May Provide Novel Therapy for Obesity and Diabetes
Triumvira snags $55M Series A to guide TAC technology to the clinic
Triumvira snags $55 million Series A to guide TAC technology to the clinic
Abbott Jumps 22% On Emergency Use Nod For Credit Card Size Covid-19 Test
Further coronavirus heart impact discovered; new clues to why women fare better than men
After an Unfortunate Surprise, Can Onconova Bounce Back? Analyst Weighs In
Additional data on blood thinner efficacy for COVID-19 and insight on best possible regimens
Research will test finger-worn sensor that tracks stroke survivors’ arm movements
Fluidigm’s Covid-19 Saliva Test Receives Emergency FDA Authorization
Hologic Snaps Up Fibroid Specialist Acessa For $80M; BTIG Bullish
WVU-led study aims to identify, relieve anxiety and depression caused by COVID-19
Medtronic Gains 4% As Quarterly Profit Tops Estimates Amid Faster Recovery
HCQ All Over Again: WaPo Trashes Blood Plasma COVID-19 Treatment After Trump Announces Breakthrough
Sequoia, General Atlantic Said To Push Oracle Bid For TikTok - Report
Editas Scores Rare Disease Tag For EDIT-301 Sickle Cell Treatment
Flexible targets help immune system make finely-tuned antibodies
2 Healthcare Stocks Under $5 That Could Deliver Triple-Digit Gains
I'm a lung doctor testing the blood plasma from COVID-19 survivors as a treatment for the sick – a century-old idea that could be a fast...
Merck Wins 2 Approvals For Keytruda Therapy In Japan
Billionaire Jim Simons Bets on These 2 "Strong Buy" Stocks
Sonnet Bio Spikes 70% In Pre-Market On FDA Covid-19 Plasma Nod